Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.50
-0.10 (-1.32%)
May 13, 2025, 4:00 PM - Market closed

Amneal Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-13.05-116.89-83.99-129.9910.6291.06
Upgrade
Depreciation & Amortization
240.82236.19229.4240.18233.41235.39
Upgrade
Other Amortization
29.1129.111.558.69.28.68
Upgrade
Loss (Gain) From Sale of Assets
------0.12
Upgrade
Asset Writedown & Restructuring Costs
-0.9266.9324.0828.5536.72
Upgrade
Stock-Based Compensation
28.327.7726.8231.8528.4120.75
Upgrade
Other Operating Activities
120.21122.08142.05-49.6765.2147.85
Upgrade
Change in Accounts Receivable
-86.32-162.64126.29-79.72-23.6216.79
Upgrade
Change in Inventory
-131.59-130.53-126.18-102.4-49.02-113.78
Upgrade
Change in Accounts Payable
60.34235.14-94.45109.57-43.930.31
Upgrade
Change in Other Net Operating Assets
59.153.9647.1512.6-17.0335.37
Upgrade
Operating Cash Flow
306.92295.1345.5865.1241.82379
Upgrade
Operating Cash Flow Growth
52.35%-14.61%430.84%-73.08%-36.20%22128.80%
Upgrade
Capital Expenditures
-64.4-60.34-46.8-48.8-50.94-61.84
Upgrade
Sale of Property, Plant & Equipment
0.52-----
Upgrade
Cash Acquisitions
----84.71-146.54-251.36
Upgrade
Divestitures
11.9911.99----
Upgrade
Sale (Purchase) of Intangibles
-9.15-14.65-22.39-41.8-1.7-4.35
Upgrade
Other Investing Activities
---15-
Upgrade
Investing Cash Flow
-61.03-63-69.19-174.31-194.18-317.55
Upgrade
Short-Term Debt Issued
-4821985--
Upgrade
Long-Term Debt Issued
--217.73--180
Upgrade
Total Debt Issued
21848436.7385-180
Upgrade
Short-Term Debt Repaid
--44.2---1-
Upgrade
Long-Term Debt Repaid
--188.92-414.08-123.27-78.18-37.01
Upgrade
Total Debt Repaid
-405.27-233.12-414.08-123.27-79.18-37.01
Upgrade
Net Debt Issued (Repaid)
-187.27-185.1222.65-38.27-79.18142.99
Upgrade
Issuance of Common Stock
1.21.150.450.660.850.32
Upgrade
Repurchase of Common Stock
-22.38-7.95-2.38-3.57-2.66-0.86
Upgrade
Other Financing Activities
-19.35-19.88-233.3-65.44-57.13-10.64
Upgrade
Financing Cash Flow
-227.8-211.79-212.57-106.62-138.12131.81
Upgrade
Foreign Exchange Rate Adjustments
-1.3-10.07-5.680.11.04
Upgrade
Net Cash Flow
16.7819.3163.88-221.51-90.38194.3
Upgrade
Free Cash Flow
242.52234.76298.7816.3190.88317.17
Upgrade
Free Cash Flow Growth
55.46%-21.43%1732.42%-91.46%-39.82%-
Upgrade
Free Cash Flow Margin
8.57%8.40%12.48%0.74%9.12%15.92%
Upgrade
Free Cash Flow Per Share
0.780.761.700.111.262.13
Upgrade
Cash Interest Paid
255.33263.52192.81142.72121.75130.19
Upgrade
Cash Income Tax Paid
14.2715.222.512.6515.56-100.14
Upgrade
Levered Free Cash Flow
311.48253.45307.26120.14217.65153.82
Upgrade
Unlevered Free Cash Flow
438.52385.98427.36210.53293.65236.39
Upgrade
Change in Net Working Capital
-15.3220.72-70.7195.9250.944.6
Upgrade
Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q